C12Y 401/01015
Glutamate decarboxylase
Official title: Glutamate decarboxylase (4.1.1.15)
C12Y401/01015 (Glutamate decarboxylase) appears on 46 US grants and 81 published applications in this corpus.
Search patents in C12Y- Granted patents
- 46
- Published applications
- 81
- Assignees
- 47
- Inventors
- 163
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 2 | 0 |
| 2005 | 0 | 3 |
| 2006 | 2 | 3 |
| 2007 | 0 | 3 |
| 2008 | 3 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 1 | 3 |
| 2016 | 2 | 6 |
| 2017 | 0 | 0 |
| 2018 | 3 | 4 |
| 2019 | 6 | 6 |
| 2020 | 1 | 5 |
| 2021 | 2 | 4 |
| 2022 | 3 | 5 |
| 2023 | 3 | 4 |
| 2024 | 2 | 13 |
| 2025 | 2 | 7 |
| 2026 | 4 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for treating pain26 May 2026US 12,636,346 B2Kolon Life Science, Inc.
- Combinations for antigen based therapy21 Apr 2026US 12,605,432 B2Diamyd Medical AB
- Viral vectors for treating neurogenic detrusor overactivity6 Jan 2026US 12,516,326 B2Assistance Publique-Hopitaux de Paris
- Viral vectors for treating neurogenic detrusor overactivity6 Jan 2026US 12,516,330 B2Assistance Publique-Hopitaux de Paris
- Glutamate decarboxylase mutant with improved pH tolerance and use thereof in synthesis of gamma-aminobutyric acid25 Nov 2025US 12,480,112 B2Jiangnan University
- Compositions and methods for using antigen-specific apoptotic dna immunotherapy to prevent and treat side effects resulting from administration of immune checkpoint inhibitors24 Sep 2026US 2026/0285979 A1Aditxt, Inc.
- Viral Vectors For Treating Neurogenic Detrusor Overactivity3 Sep 2026US 2026/0258426 A1Assistance Publique-Hopitaux de Paris
- Synthesis of versatile neuromodulatory molecules by a gut microbial glutamate decarboxylase13 Aug 2026US 2026/0234597 A1
- Combinations for Antigen Based Therapy23 Jul 2026US 2026/0207721 A1Diamyd Medical AB
- Immunotherapy30 Apr 2026US 2026/0118355 A1Diamyd Medical AB
Most cited
By later US patents
- Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase51US 5,846,740 AThe Regents of the University of California · 1998
- Peptides derived from glutamic acid decarboxylase41US 5,674,978 AThe Regents of the University of California · 1997
- Cloned glutamic acid decarboxylase peptides37US 5,475,086 AThe Regents of the University of California · 1995
- Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases35US 6,455,267 B1Diamyd Medical AB · 2002
- Chimeric proteins for diagnosis and treatment of diabetes35US 6,982,323 B1Alexion Pharmaceuticals, Inc. · 2006